Listen to ASX-listed Imugene Managing Director Leslie Chong talk to Matt Birney on the Bulls N’ Bears Report about Imugene’s “immunotherapy” drug that can laser-target cancerous cells in partnership with an already approved drug, potentially setting up a sublime pairing of products in the vanguard of the fight against cancer.
Advertisement
LATEST BUSINESS STORIES
Chris O'Keefe
02/06/2023
Chris O'Keefe
01/06/2023
Chris O'Keefe
15/05/2023
federal budget 2023
09/05/2023
federal budget 2023
09/05/2023
federal budget 2023
09/05/2023
federal budget 2023
09/05/2023
BULLS N' BEARS
24/04/2023
BULLS N' BEARS
21/04/2023
BULLS N' BEARS
20/04/2023
BULLS N' BEARS
14/04/2023
BULLS N' BEARS
13/04/2023
BULLS N' BEARS
12/04/2023
BULLS N' BEARS
11/04/2023
BULLS N' BEARS
06/04/2023
PUBLIC COMPANIES
BULLS N' BEARS
25/05/2023
BULLS N' BEARS
23/05/2023
BULLS N' BEARS
22/05/2023
Business Podcasts
Luke Grant
/ 11:10
Luke Grant
/ 12:11
Deborah Knight
/
13:01
Luke Grant
/
09:04
Luke Grant
/
09:14